| Cheplapharm Schweiz GmbH - Etopophos 1136 mg, Pulver zur Herstellung einer Infusionslösung |
| 53557 | | 02 | | Etopophos 1136 mg | | Pulver zur Herstellung einer Infusionslösung | | L01CB01 | | Etoposide | | 28.02.2000 | | |
|
| Composition |
| Praeparatio cryodesiccata: etoposidi phosphas 1136.3 mg corresp. etoposidum 1000 mg, natrii citras anhydricus corresp. natrium 76.72 mg, dextranum 40, pro vitro. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisate | | | | | | | | Active Agent | Dose |
|---|
| Etoposide Phosphate | 1136.3 mg correspond Etoposide 1000 mg |
| | BAG: Active Agent | Dose |
|---|
| Etoposide Phosphate | 1136.3 mg |
| | | | Inactive agents | Dose |
|---|
| Dextran | 40 | | Natrii Citras Anhydricus | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 031 | Durchstechflasche(n) | 364.57 | 412.90 | A | SL | No |
|
